Taricef SB 250mg/125mg Injection
Marketer
Flanca Life Sciences
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Taricef SB 250mg/125mg Injection
Cefixime and Sulbactam injection (250mg/125mg), marketed as Taricef SB, is a dual-action antibiotic. It's indicated for treating diverse bacterial infections by inhibiting microbial proliferation and halting infection progression. Administration must be solely under medical guidance; adhere strictly to the prescribed schedule. Complete the entire course of treatment, regardless of symptom improvement; premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects promptly to your physician. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Disclose all current medications to your doctor before commencing treatment. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occur. Sufficient rest, a balanced diet, and ample hydration are crucial for optimal recovery. Your physician might order lab tests to monitor treatment effectiveness.
Uses of Taricef SB 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Taricef SB 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Taricef SB 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Taricef SB 250mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Taricef SB 250mg/125mg Injection works:
The injectable formulation Taricef SB, containing 250mg Ceftriaxone and 125mg Sulbactam, utilizes a dual-drug approach. Ceftriaxone, a broad-spectrum antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Taricef SB 250mg/125mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectible medication Taricef SB, containing 250mg/125mg, is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; however, clinical data from human studies remain scarce.
Breast feedingCAUTION
Administering Taricef SB 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Taricef SB 250mg/125mg Injection can lead to reduced awareness, visual disturbances, drowsiness, and dizziness. Operation of a vehicle should be avoided if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Taricef SB 250mg/125mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Individuals with severe hepatic impairment should use Taricef SB 250mg/125mg Injection cautiously, potentially requiring a modified dosage. A physician's consultation is advised. Dosage alteration for Taricef SB 250mg/125mg Injection isn't suggested for those with mild to moderate liver dysfunction.
What if you forget to take Taricef SB 250mg/125mg Injection :
Should you inadvertently omit a scheduled dose of Taricef SB 250mg/125mg Injection, seek advice from your physician.
Facts to Know About Taricef SB 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently